Supernus Pharmaceuticals, Inc.

Manager, Accounting R&D

Supernus Pharmaceuticals, Inc.  •  $100k - $125k/yr  •  Rockville, MD (Onsite)  •  1 month ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Supernus Pharmaceuticals is an award-winning biopharmaceutical company with more than 30 years of experience in developing and commercializing products that treat central nervous system (CNS) diseases. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. We currently have 8 products in the market that are making a real impact on patient outcomes.

The R&D Finance Manager is a key member of the Finance organization that directly supports our R&D organization. This role works closely across multiple departments and functions. The R&D Finance Manager will support the R&D Finance team in operating expense related forecasting and accounting.

Essential Duties & Responsibilities:

  • Responsible for numerous daily accounting activities including, but not limited to, assisting with the monthly accounting R&D close process, general ledger accounting, and account reconciliations.
  • Support the finance team and other stakeholders with the annual budgeting and quarterly forecasting process. Review departmental budgets and offer feedback and support to budget holders.
  • Review/conduct variance analysis and partner with R&D teams to accurately project spend.
  • Support contract review and full procure to pay cycle for R&D agreements.
  • Assist the finance group and other key personnel with the ongoing transition to a new budgeting platform.
  • Communicate with departments and vendors as needed to ensure all invoices are processed and that all financial information is accurate at the end of each month.
  • Assist with developing and preparing quarterly audit & forecast schedules.
  • Other ad-hoc research, data analysis, department financial planning or LRP projects as needed.

Knowledge and Other Qualifications:

  • Bachelor’s in accounting required.
  • Certified Public Accountant (CPA) preferred.
  • 5+ years minimum relevant experience or at least 3+ years Big 4 public accounting.
  • Strong knowledge of Microsoft Office, particularly Excel required.
  • Prior life sciences or software industry public company experience preferred.
  • Able to extract pertinent data from ERP system or other sources to support above duties, comfortable working with large data sets.
  • Passionate about business excellence and continuous improvement in processes.
  • Strong communication skills (written and oral) and a demonstrated ability to work effectively across functions.
  • Strong analytical, organizational, and time management skills.
  • Confidentiality and Integrity - must be able to represent and model integrity within the organization. Must possess and maintain the highest degree of security and confidentiality of information.

Other Characteristics:

  • Self-starter with a proven ability to work with minimal supervision.
  • Ability to work independently and as part of a team. Resourceful and innovative in approach to work.
  • Ability to work well under pressure, meet deadlines and deliver on commitments.
  • Consistently exhibit Supernus Values in interactions with employees at all levels of the organization, vendors, customers and others.
  • Maintains high ethical standards of integrity and quality.
  • Authorized to legally work in the United States without visa sponsorship.

Physical Requirements / Work Environment:

  • Sedentary work. Exerting up to 10 pounds of force occasionally and/or carrying objects. Sedentary work involves sitting most of the time.
  • The worker is required to have close visual acuity to perform an activity such as: preparing and analyzing data and figures; transcribing; viewing a computer screen, iPad, or other electronic device; and extensive reading.
  • The worker is not substantially exposed to adverse environmental conditions.

Compensation:

At Supernus, we offer a competitive compensation package that reflects your experiences and contributions. The expected salary range for fully qualified candidates applying for this role is $100,000 to $125,000. This range is what the Company reasonably expects to offer for the position and is not reflective of the full compensation scale of the role. This range may be modified in the future. An individual’s salary within the range is based on multiple factors, which may include and are not limited to education, relevant experience, knowledge, length of industry experience and organizational needs.

You also will be able to participate in a competitive benefits package, including but not limited to: health, dental, vision, paid time off, 401k company match, company paid life insurance and health and wellness benefits. The total compensation package for this position also includes other compensation elements such as stock equity awards, employee stock purchase programs and participation in our Company’s discretionary annual bonus program.

Supernus Pharmaceuticals is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, national origin, disability, protected veteran status, age or any other characteristic protected by law.

Supernus Pharmaceuticals, Inc.

About Supernus Pharmaceuticals, Inc.

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.

We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility.

We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

Industry
Chemicals & Materials
Company Size
501-1,000 employees
Headquarters
Rockville, Maryland
Year Founded
2005
Social Media